PT1427748E - 17alfa-hidroxi-14beta-esteróides com efeito hormonal - Google Patents

17alfa-hidroxi-14beta-esteróides com efeito hormonal Download PDF

Info

Publication number
PT1427748E
PT1427748E PT02777036T PT02777036T PT1427748E PT 1427748 E PT1427748 E PT 1427748E PT 02777036 T PT02777036 T PT 02777036T PT 02777036 T PT02777036 T PT 02777036T PT 1427748 E PT1427748 E PT 1427748E
Authority
PT
Portugal
Prior art keywords
14beta
17alpha
steroids
hydroxy
hormonal effect
Prior art date
Application number
PT02777036T
Other languages
English (en)
Portuguese (pt)
Inventor
Dirk Leysen
Jaap Van Der Louw
Marcel Evert De Gooijer
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180920&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1427748(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Organon Nv filed Critical Organon Nv
Publication of PT1427748E publication Critical patent/PT1427748E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT02777036T 2001-09-12 2002-09-06 17alfa-hidroxi-14beta-esteróides com efeito hormonal PT1427748E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01203455 2001-09-12

Publications (1)

Publication Number Publication Date
PT1427748E true PT1427748E (pt) 2008-08-27

Family

ID=8180920

Family Applications (1)

Application Number Title Priority Date Filing Date
PT02777036T PT1427748E (pt) 2001-09-12 2002-09-06 17alfa-hidroxi-14beta-esteróides com efeito hormonal

Country Status (28)

Country Link
US (1) US7169769B2 (enExample)
EP (1) EP1427748B1 (enExample)
JP (1) JP4471653B2 (enExample)
KR (1) KR100940054B1 (enExample)
CN (1) CN1257913C (enExample)
AR (1) AR036462A1 (enExample)
AT (1) ATE395352T1 (enExample)
AU (1) AU2002339536B2 (enExample)
BR (1) BR0212409A (enExample)
CA (1) CA2505575C (enExample)
CY (1) CY1108152T1 (enExample)
DE (1) DE60226623D1 (enExample)
DK (1) DK1427748T3 (enExample)
EC (1) ECSP045012A (enExample)
ES (1) ES2305306T3 (enExample)
HR (1) HRP20040193A2 (enExample)
HU (1) HUP0402139A3 (enExample)
IL (2) IL160451A0 (enExample)
IS (1) IS2555B (enExample)
MX (1) MXPA04002418A (enExample)
NO (1) NO326624B1 (enExample)
NZ (1) NZ531487A (enExample)
PL (1) PL207493B1 (enExample)
PT (1) PT1427748E (enExample)
RU (1) RU2294332C2 (enExample)
TW (1) TWI221154B (enExample)
WO (1) WO2003022864A1 (enExample)
ZA (1) ZA200401992B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338925A (en) * 1965-10-25 1967-08-29 Syntex Corp 17-substituted 14beta-estr-4-enes
CA2359218A1 (en) 1999-03-08 2000-09-14 Akzo Nobel N.V. 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
US6905714B2 (en) * 2000-02-29 2005-06-14 National University Of Singapore Method for modulating steroidogenic activity
US6391868B2 (en) * 2000-05-10 2002-05-21 Lpt Research, Inc. Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Also Published As

Publication number Publication date
US20040259849A1 (en) 2004-12-23
PL207493B1 (pl) 2010-12-31
ES2305306T3 (es) 2008-11-01
KR20040039346A (ko) 2004-05-10
AR036462A1 (es) 2004-09-08
NZ531487A (en) 2005-08-26
EP1427748B1 (en) 2008-05-14
IL160451A (en) 2009-11-18
ECSP045012A (es) 2004-09-27
IS7165A (is) 2004-02-26
CA2505575A1 (en) 2003-03-20
TWI221154B (en) 2004-09-21
EP1427748A1 (en) 2004-06-16
DE60226623D1 (de) 2008-06-26
MXPA04002418A (es) 2004-07-30
PL368727A1 (en) 2005-04-04
HRP20040193A2 (en) 2004-08-31
HUP0402139A3 (en) 2012-12-28
IL160451A0 (en) 2004-07-25
KR100940054B1 (ko) 2010-02-04
CN1553917A (zh) 2004-12-08
HK1063637A1 (en) 2005-01-07
CN1257913C (zh) 2006-05-31
AU2002339536B2 (en) 2008-04-24
RU2294332C2 (ru) 2007-02-27
NO20041010L (no) 2004-03-10
BR0212409A (pt) 2004-08-03
CA2505575C (en) 2010-01-26
JP2005505566A (ja) 2005-02-24
CY1108152T1 (el) 2014-02-12
DK1427748T3 (da) 2008-09-08
WO2003022864A1 (en) 2003-03-20
NO326624B1 (no) 2009-01-19
US7169769B2 (en) 2007-01-30
JP4471653B2 (ja) 2010-06-02
ATE395352T1 (de) 2008-05-15
ZA200401992B (en) 2005-04-21
HUP0402139A2 (hu) 2005-02-28
IS2555B (is) 2009-10-15
RU2004110934A (ru) 2005-08-20

Similar Documents

Publication Publication Date Title
DE60231477D1 (en) Imidazolderivate
DE60210819D1 (en) Pyrazolopyridazinderivate
GB2392916B (en) Deicing
DE60107296D1 (en) Kabelverstärkerverbindungsanordnung
DE60204140D1 (en) 5-ethyl-imidazotriazinone
EP1408979A4 (en) R-6-HYDROXY-BUSPIRONE
DE60236364D1 (en) Hepatitis-c-virus-impfstoff
GB0114007D0 (en) Oilgonucleotides
PL368727A1 (en) 17alpha-hydroxy-14beta-steroids with hormonal effect
GB0105568D0 (en) Bike-secure
GB0112053D0 (en) Bacsac
CA91502S (en) Bedboard
GB0103994D0 (en) Degravitator
GB0107567D0 (en) Visor-demister
GB0100053D0 (en) Xfercard
GB0101106D0 (en) Roof-sava
GB0101272D0 (en) Aquaneo
GB0102149D0 (en) Plant - remover
GB0103369D0 (en) Electric-waterbottle
GB0103796D0 (en) EMeal
GB0103800D0 (en) Deucer
AU148130S (en) Weighscales
GB0105543D0 (en) Hygiene-glove
GB0105551D0 (en) Satshot
AU146973S (en) Neckerchief